Iron, hemochromatosis, and hepatocellular carcinoma

Gastroenterology

Volumn 127, Issue 5 SUPPL., 2004, Pages

  Kowdley, Kris V ^a,b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; INDUCIBLE NITRIC OXIDE SYNTHASE; IRON; PROTEIN P53; TRANSFERRIN;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; BETA THALASSEMIA; CANCER RISK; CELL PROLIFERATION; CONFERENCE PAPER; DNA DAMAGE; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOSITY; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; IRON OVERLOAD; IRON STORAGE; KIDNEY FAILURE; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 7044222320     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gastro.2004.09.019     Document Type: Conference Paper

References (53)

1. C. Niederau, R. Fischer, A. Sonnenberg, W. Stremmel, H.J. Trampisch, G. Strohmeyer Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis N Engl J Med 313 1985 1256 1262
2. R.A. Bradbear, C. Bain, V. Siskind, F.D. Schofield, S. Webb, E.M. Axelsen, J.W. Halliday, M.L. Bassett, L.W. Powell Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases J Natl Cancer Inst 75 1985 81 84
3. G. Strohmeyer, C. Niederau, W. Stremmel Survival and causes of death in hemochromatosis. Observations in 163 patients Ann N Y Acad Sci 526 1988 245 257
4. A.W. Hsing, J.K. McLaughlin, J.H. Olsen, L. Mellemkjar, S. Wacholder, J.F. Fraumeni Jr Cancer risk following primary hemochromatosis a population-based cohort study in Denmark Int J Cancer 60 1995 160 162
5. P.C. Adams Hepatocellular carcinoma in hereditary hemochromatosis Can J Gastorenterol 7 1993 37 41
6. Q. Yang, S.M. McDonnell, M.J. Khoury, J. Cono, R.G. Parrish Hemochromatosis-associated mortality in the United States from 1979 to 1992 an analysis of multiple-cause mortality data Ann Intern Med 129 1998 946 953
7. M. Elmberg, R. Hultcrantz, A. Ekbom, L. Brandt, S. Olsson, R. Olsson, S. Lindgren, L. Loof, P. Stal, S. Wallerstedt, S. Almer, H. Sandberg-Gertzen, J. Askling Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives Gastroenterology 125 2003 1733 1741
8. P.C. Adams, M. Speechley, A.E. Kertesz Long-term survival analysis in hereditary hemochromatosis Gastroenterology 101 1991 368 372
9. J.E. Haddow, G.E. Palomaki, M. McClain, W. Craig Hereditary haemochromatosis and hepatocellular carcinoma in males a strategy for estimating the potential for primary prevention J Med Screen 10 2003 11 13
10. A.L. Fracanzani, D. Conte, M. Fraquelli, E. Taioli, M. Mattioli, A. Losco, S. Fargion Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease Hepatology 33 2001 647 651
11. D.T. Purtilo, L.S. Gottlieb Cirrhosis and hepatoma occurring at Boston City Hospital (1917-1968) Cancer 32 1973 458 462
12. R.N. MacSween, A.R. Scott Hepatic cirrhosis a clinico-pathological review of 520 cases J Clin Pathol 26 1973 936 942
13. M.A. Mallory, K.V. Kowdley Hereditary hemochromatosis and cancer risk more fuel to the fire? Gastroenterology 121 2001 1253 1254
14. R.W. Ammann, E. Muller, J. Bansky, G. Schuler, W.H. Hacki High incidence of extrahepatic carcinomas in idiopathic hemochromatosis Scand J Gastroenterol 15 1980 733 736
15. A. Bomford, R. Williams Long term results of venesection therapy in idiopathic haemochromatosis QJM 45 1976 611 623
16. J.V. Selby, G.D. Friedman Epidemiologic evidence of an association between body iron stores and risk of cancer Int J Cancer 41 1988 677 682
17. L.J. Herrinton, G.D. Friedman, D. Baer, J.V. Selby Transferrin saturation and risk of cancer Am J Epidemiol 142 1995 692 698
18. R.G. Stevens, B.I. Graubard, M.S. Micozzi, K. Neriishi, B.S. Blumberg Moderate elevation of body iron level and increased risk of cancer occurrence and death Int J Cancer 56 1994 364 369
19. R.G. Stevens, D.Y. Jones, M.S. Micozzi, P.R. Taylor Body iron stores and the risk of cancer N Engl J Med 319 1988 1047 1052
20. S. Fargion, C. Mandelli, A. Piperno, B. Cesana, A.L. Fracanzani, M. Fraquelli, P.A. Bianchi, G. Fiorelli, D. Conte Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis Hepatology 15 1992 655 659
21. C. Borgna-Pignatti, G. Vergine, T. Lombardo, M.D. Cappellini, P. Cianciulli, A. Maggio, D. Renda, M.E. Lai, A. Mandas, G. Forni, A. Piga, M.G. Bisconte Hepatocellular carcinoma in the thalassaemia syndromes Br J Haematol 124 2004 114 117
22. E. Beutler, J.C. Barton, V.J. Felitti, T. Gelbart, C. West, P.L. Lee, J. Waalen, C. Vulpe Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans Blood Cells Mol Dis 31 2003 305 309
23. V.R. Gordeuk, A. Caleffi, E. Corradini, F. Ferrara, R.A. Jones, O. Castro, O. Onyekwere, R. Kittles, E. Pignatti, G. Montosi, C. Garuti, I.T. Gangaidzo, Z.A. Gomo, V.M. Moyo, T.A. Rouault, P. MacPhail, A. Pietrangelo Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene Blood Cells Mol Dis 31 2003 299 304
24. E. Mandishona, A.P. MacPhail, V.R. Gordeuk, M.A. Kedda, A.C. Paterson, T.A. Rouault, M.C. Kew Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans Hepatology 27 1998 1563 1566
25. V.M. Moyo, R. Makunike, I.T. Gangaidzo, V.R. Gordeuk, C.E. McLaren, H. Khumalo, T. Saungweme, T. Rouault, C.F. Kiire African iron overload and hepatocellular carcinoma (HA-7-0-080) Eur J Haematol 60 1998 28 34
26. C. Hellerbrand, A. Poppl, A. Hartmann, J. Scholmerich, G. Lock HFE C282Y heterozygosity in hepatocellular carcinoma evidence for an increased prevalence Clin Gastroenterol Hepatol 1 2003 279 284
27. C. Chapoutot, M. Esslimani, Z. Joomaye, J. Ramos, P. Perney, C. Laurent, P. Fabbro-Peray, D. Larrey, J. Domergue, F. Blanc Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis Gut 46 2000 711 714
28. S. Fargion, M.A. Stazi, A.L. Fracanzani, M. Mattioli, M. Sampietro, D. Tavazzi, C. Bertelli, V. Patriarca, C. Mariani, G. Fiorelli Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma Blood Cells Mol Dis 27 2001 505 511
29. E. Cauza, M. Peck-Radosavljevic, H. Ulrich-Pur, C. Datz, M. Gschwantler, M. Schoniger-Hekele, F. Hackl, C. Polli, S. Rasoul-Rockenschaub, C. Muller, F. Wrba, A. Gangl, P. Ferenci Mutations of the HFE gene in patients with hepatocellular carcinoma Am J Gastroenterol 98 2003 442 447
30. E. Lauret, M. Rodriguez, S. Gonzalez, A. Linares, A. Lopez-Vazquez, J. Martinez-Borra, L. Rodrigo, C. Lopez-Larrea HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma Am J Gastroenterol 97 2002 1016 1021
31. V. Boige, L. Castera, N. de Roux, N. Ganne-Carrie, B. Ducot, G. Pelletier, M. Beaugrand, C. Buffet Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis Gut 52 2003 1178 1181
32. K.V. Kowdley, T. Hassanein, S. Kaur, F.J. Farrell, D.H. Van Thiel, E.B. Keeffe, M.F. Sorrell, B.R. Bacon, F.L. Weber Jr, A.S. Tavill Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis Liver Transpl Surg 1 1995 237 241
33. K.V. Kowdley, B. Tung, D. Brandhagen, M. Schilsky, S.H. Han, S. Cotler, J. Weinstein, R. Gish, N. Bass, B. Bacon, R. Sterling, R. Fontana Prevalence of hepatic iron overload and HFE mutations among patients undergoing orthotopic liver transplantation (OLT) interim results from the National Hemochromatosis Transplant Registry (NHTR) Hepatology 34 2001 205A
34. M. Pirisi, P. Toniutto, A. Uzzau, C. Fabris, C. Avellini, C. Scott, L. Apollonio, C.A. Beltrami, F. Bresadola Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients Cancer 89 2000 297 302
35. N. Ganne-Carrie, C. Christidis, C. Chastang, M. Ziol, F. Chapel, F. Imbert-Bismut, J.C. Trinchet, C. Guettier, M. Beaugrand Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study Gut 46 2000 277 282
36. B. Turlin, F. Juguet, R. Moirand, D. Le Quilleuc, O. Loreal, J.P. Campion, B. Launois, M.P. Ramee, P. Brissot, Y. Deugnier Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver Hepatology 22 1995 446 450
37. J.F. Blanc, V. De Ledinghen, P.H. Bernard, H. de Verneuil, M. Winnock, B. Le Bail, J. Carles, J. Saric, C. Balabaud, P. Bioulac-Sage Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver J Hepatol 32 2000 805 811
38. M.P. Bralet, J.M. Regimbeau, P. Pineau, S. Dubois, G. Loas, F. Degos, D. Valla, J. Belghiti, C. Degott, B. Terris Hepatocellular carcinoma occurring in nonfibrotic liver epidemiologic and histopathologic analysis of 80 French cases Hepatology 32 2000 200 204
39. G.N. Ioannou, K.V. Kowdley Iron, HFE mutations, and hepatocellular carcinoma is hepatic iron a carcinogen? Clin Gastroenterol Hepatol 1 2003 246 248
40. N. Chenoufi, O. Loreal, B. Drenou, S. Cariou, N. Hubert, P. Leroyer, P. Brissot, G. Lescoat Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate J Hepatol 26 1997 650 658
41. H.W. Hann, M.W. Stahlhut, C.L. Hann Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines Hepatology 11 1990 566 569
42. Y. Deugnier, B. Turlin Iron and hepatocellular carcinoma J Gastroenterol Hepatol 16 2001 491 494
43. L.A. Loeb, E.A. James, A.M. Waltersdorph, S.J. Klebanoff Mutagenesis by the autoxidation of iron with isolated DNA Proc Natl Acad Sci U S A 85 1988 3918 3922
44. R. Meneghini Iron homeostasis, oxidative stress, and DNA damage Free Radic Biol Med 23 1997 783 792
45. G. Vautier, A.B. Bomford, B.C. Portmann, E. Metivier, R. Williams, S.D. Ryder p53 mutations in British patients with hepatocellular carcinoma clustering in genetic hemochromatosis Gastroenterology 117 1999 154 160
46. Y. Cho, S. Gorina, P.D. Jeffrey, N.P. Pavletich Crystal structure of a p53 tumor suppressor-DNA complex understanding tumorigenic mutations Science 265 1994 346 355
47. S.P. Hussain, K. Raja, P.A. Amstad, M. Sawyer, L.J. Trudel, G.N. Wogan, L.J. Hofseth, P.G. Shields, T.R. Billiar, C. Trautwein, T. Hohler, P.R. Galle, D.H. Phillips, R. Markin, A.J. Marrogi, C.C. Harris Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis oxyradical overload diseases Proc Natl Acad Sci U S A 97 2000 12770 12775
48. A.J. Marrogi, M.A. Khan, H.E. van Gijssel, J.A. Welsh, H. Rahim, A.J. Demetris, K.V. Kowdley, S.P. Hussain, J. Nair, H. Bartsch, N. Okby, M.C. Poirier, K.G. Ishak, C.C. Harris Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma J Natl Cancer Inst 93 2001 1652 1655
49. S.P. Hussain, C.C. Harris Molecular epidemiology and carcinogenesis endogenous and exogenous carcinogens Mutat Res 462 2000 311 322
50. K. Houglum, G.A. Ramm, D.H. Crawford, J.L. Witztum, L.W. Powell, M. Chojkier Excess iron induces hepatic oxidative stress and transforming growth factorbeta1 in genetic hemochromatosis Hepatology 26 1997 605 610
51. C.A. Seymour, T.J. Peters Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes Br J Haematol 40 1978 239 253
52. L.H. Breimer Repair of DNA damage induced by reactive oxygen species Free Radic Res Commun 14 1991 159 171
53. R. Green, I. Esparza, R. Schreiber Iron inhibits the nonspecific tumoricidal activity of macrophages. A possible contributory mechanism for neoplasia in hemochromatosis Ann N Y Acad Sci 526 1988 301 309